The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Particle-Enhanced Turbidimetric Immunoassay-Global Market Insights and Sales Trends 2024
Synopsis
Particle-Enhanced Turbidimetric Immunoassays or PETIA is a biochemical process which uses optical change i.e. change in opaqueness caused by the agglutination of immunoparticles in the sample. These immunopartilcles are nothing but nanoparticles coated with antibodies. Their reaction with taken sample makes the mixture cloudy. A monochromatic light is then passed through the mixture to determine the opaqueness of turbidity of the mixture. Based on the absorption of light and pre-determined calibrations as per known and standardized concentrations, quantitative measurements of body fluid components like proteins, pathogens, serums, urine, plasma, etc can then be taken.
The global Particle-Enhanced Turbidimetric Immunoassay market size is expected to reach US$ 3076.7 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Particle-Enhanced Turbidimetric Immunoassay in various end use industries. The expanding demands from the Hospitals, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies and Others, are propelling Particle-Enhanced Turbidimetric Immunoassay market. Kits or Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan's data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Particle-Enhanced Turbidimetric Immunoassay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Particle-Enhanced Turbidimetric Immunoassay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Particle-Enhanced Turbidimetric Immunoassay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Particle-Enhanced Turbidimetric Immunoassay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Particle-Enhanced Turbidimetric Immunoassay covered in this report include Gentian Diagnostics, Thermo-Fisher Scientific, Buehlmann, Biotec, Abbott Laboratories, Roche, Siemens, Danaher Corporation and Diasorin SPA, etc.
The global Particle-Enhanced Turbidimetric Immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gentian Diagnostics
Thermo-Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Global Particle-Enhanced Turbidimetric Immunoassay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Particle-Enhanced Turbidimetric Immunoassay market, Segment by Type:
Kits or Reagents
Service
Global Particle-Enhanced Turbidimetric Immunoassay market, by Application
Hospitals
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Particle-Enhanced Turbidimetric Immunoassay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Particle-Enhanced Turbidimetric Immunoassays or PETIA is a biochemical process which uses optical change i.e. change in opaqueness caused by the agglutination of immunoparticles in the sample. These immunopartilcles are nothing but nanoparticles coated with antibodies. Their reaction with taken sample makes the mixture cloudy. A monochromatic light is then passed through the mixture to determine the opaqueness of turbidity of the mixture. Based on the absorption of light and pre-determined calibrations as per known and standardized concentrations, quantitative measurements of body fluid components like proteins, pathogens, serums, urine, plasma, etc can then be taken.
The global Particle-Enhanced Turbidimetric Immunoassay market size is expected to reach US$ 3076.7 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Particle-Enhanced Turbidimetric Immunoassay in various end use industries. The expanding demands from the Hospitals, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies and Others, are propelling Particle-Enhanced Turbidimetric Immunoassay market. Kits or Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan's data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Particle-Enhanced Turbidimetric Immunoassay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Particle-Enhanced Turbidimetric Immunoassay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Particle-Enhanced Turbidimetric Immunoassay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Particle-Enhanced Turbidimetric Immunoassay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Particle-Enhanced Turbidimetric Immunoassay covered in this report include Gentian Diagnostics, Thermo-Fisher Scientific, Buehlmann, Biotec, Abbott Laboratories, Roche, Siemens, Danaher Corporation and Diasorin SPA, etc.
The global Particle-Enhanced Turbidimetric Immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gentian Diagnostics
Thermo-Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Global Particle-Enhanced Turbidimetric Immunoassay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Particle-Enhanced Turbidimetric Immunoassay market, Segment by Type:
Kits or Reagents
Service
Global Particle-Enhanced Turbidimetric Immunoassay market, by Application
Hospitals
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Particle-Enhanced Turbidimetric Immunoassay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Particle-Enhanced Turbidimetric Immunoassay
1.1 Particle-Enhanced Turbidimetric Immunoassay Market Overview
1.1.1 Particle-Enhanced Turbidimetric Immunoassay Product Scope
1.1.2 Particle-Enhanced Turbidimetric Immunoassay Market Status and Outlook
1.2 Global Particle-Enhanced Turbidimetric Immunoassay Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2018-2029)
1.4 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Region (2018-2023)
1.5 Global Particle-Enhanced Turbidimetric Immunoassay Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Particle-Enhanced Turbidimetric Immunoassay Market Size (2018-2029)
1.6.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size (2018-2029)
1.6.2 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size (2018-2029)
1.6.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size (2018-2029)
1.6.4 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size (2018-2029)
1.6.5 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size (2018-2029)
2 Particle-Enhanced Turbidimetric Immunoassay Market by Type
2.1 Introduction
2.1.1 Kits or Reagents
2.1.2 Service
2.2 Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Type (2018-2023)
2.2.2 Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Type (2018-2029)
3 Particle-Enhanced Turbidimetric Immunoassay Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Academic and Research Institutions
3.1.3 Pharmaceutical and Biotechnology Companies
3.1.4 Others
3.2 Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Application (2018-2023)
3.2.2 Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Particle-Enhanced Turbidimetric Immunoassay Revenue Breakdown by Application (2018-2029)
4 Particle-Enhanced Turbidimetric Immunoassay Competition Analysis by Players
4.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Particle-Enhanced Turbidimetric Immunoassay as of 2022)
4.3 Date of Key Players Enter into Particle-Enhanced Turbidimetric Immunoassay Market
4.4 Global Top Players Particle-Enhanced Turbidimetric Immunoassay Headquarters and Area Served
4.5 Key Players Particle-Enhanced Turbidimetric Immunoassay Product Solution and Service
4.6 Competitive Status
4.6.1 Particle-Enhanced Turbidimetric Immunoassay Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Gentian Diagnostics
5.1.1 Gentian Diagnostics Profile
5.1.2 Gentian Diagnostics Main Business
5.1.3 Gentian Diagnostics Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.1.4 Gentian Diagnostics Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.1.5 Gentian Diagnostics Recent Developments
5.2 Thermo-Fisher Scientific
5.2.1 Thermo-Fisher Scientific Profile
5.2.2 Thermo-Fisher Scientific Main Business
5.2.3 Thermo-Fisher Scientific Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.2.4 Thermo-Fisher Scientific Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo-Fisher Scientific Recent Developments
5.3 Buehlmann
5.3.1 Buehlmann Profile
5.3.2 Buehlmann Main Business
5.3.3 Buehlmann Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.3.4 Buehlmann Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.3.5 Biotec Recent Developments
5.4 Biotec
5.4.1 Biotec Profile
5.4.2 Biotec Main Business
5.4.3 Biotec Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.4.4 Biotec Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.4.5 Biotec Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.5.4 Abbott Laboratories Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.6.4 Roche Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Siemens
5.7.1 Siemens Profile
5.7.2 Siemens Main Business
5.7.3 Siemens Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.7.4 Siemens Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.7.5 Siemens Recent Developments
5.8 Danaher Corporation
5.8.1 Danaher Corporation Profile
5.8.2 Danaher Corporation Main Business
5.8.3 Danaher Corporation Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.8.4 Danaher Corporation Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.8.5 Danaher Corporation Recent Developments
5.9 Diasorin SPA
5.9.1 Diasorin SPA Profile
5.9.2 Diasorin SPA Main Business
5.9.3 Diasorin SPA Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.9.4 Diasorin SPA Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.9.5 Diasorin SPA Recent Developments
5.10 Sysmex Corporation
5.10.1 Sysmex Corporation Profile
5.10.2 Sysmex Corporation Main Business
5.10.3 Sysmex Corporation Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.10.4 Sysmex Corporation Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.10.5 Sysmex Corporation Recent Developments
5.11 Biomerieux
5.11.1 Biomerieux Profile
5.11.2 Biomerieux Main Business
5.11.3 Biomerieux Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.11.4 Biomerieux Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.11.5 Biomerieux Recent Developments
5.12 QIAGEN
5.12.1 QIAGEN Profile
5.12.2 QIAGEN Main Business
5.12.3 QIAGEN Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.12.4 QIAGEN Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.12.5 QIAGEN Recent Developments
5.13 Agilent Technologies
5.13.1 Agilent Technologies Profile
5.13.2 Agilent Technologies Main Business
5.13.3 Agilent Technologies Particle-Enhanced Turbidimetric Immunoassay Products, Services and Solutions
5.13.4 Agilent Technologies Particle-Enhanced Turbidimetric Immunoassay Revenue (US$ Million) & (2018-2023)
5.13.5 Agilent Technologies Recent Developments
6 North America
6.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Particle-Enhanced Turbidimetric Immunoassay Market Dynamics
11.1 Particle-Enhanced Turbidimetric Immunoassay Industry Trends
11.2 Particle-Enhanced Turbidimetric Immunoassay Market Drivers
11.3 Particle-Enhanced Turbidimetric Immunoassay Market Challenges
11.4 Particle-Enhanced Turbidimetric Immunoassay Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
